Publications by authors named "A Flotats"
The added value of [F]fluorocholine PET/TC in the assessment of secondary or tertiary hyperparathyroidism.
Rev Esp Med Nucl Imagen Mol (Engl Ed)
May 2024
Aim: We performed a systematic survey to assess the existing gaps in Europe in multidisciplinary education for integration of radioligand therapy (RLT) into cancer care and to obtain detailed information on the current limitations and key contents relevant.
Methods: A high-quality questionnaire, with emphasis on survey scales, formulation, and validity of the different items, was designed. An expert validation process was undertaken.
Aim: to assess if the use of an audiovisual intervention in the uptake room and/or in the scanning room, could help to reduce anxiety during [18F]FDG PET/CT imaging.
Methods: We prospectively studied 120 patients referred for [18F]FDG PET/CT imaging. Patients were allocated in 4 groups of 30 patients depending on the use of the audiovisual intervention: (1) no audiovisual intervention; (2) audiovisual intervention only in the uptake room; (3) audiovisual intervention only in the scanning room; (4) audiovisual intervention in the uptake and the scanning rooms.
Article Synopsis
- CZT-based detectors are more sensitive than conventional Anger-MPI in diagnosing coronary artery disease (CAD) during myocardial perfusion imaging (MPI), but they show lower specificity and accuracy.
- The study involved 83 patients who underwent stress/rest tests with both CZT and conventional SPECT cameras, with 15 international readers evaluating the images for comparison.
- Results indicated that while CZT-MPI had better image quality and higher sensitivity (87.5% vs. 62.5%), it also had significantly lower specificity (40% vs. 100%), highlighting the need for additional training for less experienced readers.
Although there is evidence that chemotherapy can have side effects on metabolism and brain function, there are few studies on the occurrence of these side effects with immunotherapy. The present study was conducted to assess whether brain metabolic changes occur in patients with malignant melanoma under immunotherapy. Thirty-nine patients after surgical intervention and with a diagnosis of malignant melanoma were retrospectively included and were divided into two groups: one group under the first-line therapy with anti-programmed cell death-1 ± anti-cytotoxic T lymphocyte antigen-4 monoclonal antibodies and the other group without any treatment after surgery, which served as a control.
View Article and Find Full Text PDF